Create a notes on WBC disorders based on dacie and lewis, McKenzie textbook of hematology for pathology residents

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching Images

neutrophilia toxic granulation Dohle bodies peripheral blood smear

Peripheral blood smear from a patient with suspected chronic lymphocytic leukemia (CLL) shows a predominance of small, mature-appearing lymphocytes with scant cytoplasm and clumped nuclear chromatin, accompanied by fragile cells that readily disrupt during smear preparation, producing numerous smudge or basket cells visible on the slide. The image depicts a single smudge cell in the upper right, with numerous small darkly staining lymphocytes occupying the field. The smear was prepared with Wright-Giemsa stain and examined under light microscopy at high magnification (approximately 1000x total magnification with oil immersion). Clinically, CLL is defined by absolute mature lymphocytosis of ≥5.0 × 10^9/L sustained for ≥3 months, often asymptomatic and detected incidentally on complete blood count. Morphology alone is insufficient for diagnosis; immunophenotyping showing co-expression of CD5, CD19, CD23 with weak surface immunoglobulin and light chain restriction supports CLL diagnosis. Smudge cells result from fragile leukemic cells and reflect underlying cytoskeletal fragility, though they are not specific. The image illustrates typical features: monomorphic lymphocytes, scant cytoplasm, condensed chromatin, and absent prominent nucleoli. This finding has diagnostic significance, guiding further workup, including flow cytometry, cytogenetics, and molecular studies, to distinguish CLL from other chronic lymphoproliferative disorders such as small lymphocytic lymphoma (SLL), mantle cell lymphoma, prolymphocytic leukemia, and reactive lymphocytosis.

Peripheral blood smear from a patient with suspected chronic lymphocytic leukemia (CLL) shows a predominance of small, mature-appearing lymphocytes with scant cytoplasm and clumped nuclear chromatin, accompanied by fragile cells that readily disrupt during smear preparation, producing numerous smudge or basket cells visible on the slide. The image depicts a single smudge cell in the upper right, with numerous small darkly staining lymphocytes occupying the field. The smear was prepared with Wright-Giemsa stain and examined under light microscopy at high magnification (approximately 1000x total magnification with oil immersion). Clinically, CLL is defined by absolute mature lymphocytosis of ≥5.0 × 10^9/L sustained for ≥3 months, often asymptomatic and detected incidentally on complete blood count. Morphology alone is insufficient for diagnosis; immunophenotyping showing co-expression of CD5, CD19, CD23 with weak surface immunoglobulin and light chain restriction supports CLL diagnosis. Smudge cells result from fragile leukemic cells and reflect underlying cytoskeletal fragility, though they are not specific. The image illustrates typical features: monomorphic lymphocytes, scant cytoplasm, condensed chromatin, and absent prominent nucleoli. This finding has diagnostic significance, guiding further workup, including flow cytometry, cytogenetics, and molecular studies, to distinguish CLL from other chronic lymphoproliferative disorders such as small lymphocytic lymphoma (SLL), mantle cell lymphoma, prolymphocytic leukemia, and reactive lymphocytosis.

This image depicts a peripheral blood smear prepared with Wright-Giemsa stain and examined under light microscopy at high magnification. The predominant features are small, mature-appearing lymphocytes with scant cytoplasm and discrete basophilic nuclei interspersed among erythrocytes. A characteristic subset of circulating lymphocytes displays short, polarity-restricted cytoplasmic villi (finger-like projections) consistent with splenic marginal zone lymphoma (SMZL) involvement of peripheral blood. The villi are typically slender and localized to one pole of the cell, unlike the longer, circumferential villous extensions seen in hairy cell leukemia, which aids in differential diagnosis. Some lymphocytes appear slightly irregular or irregular nuclear contours; occasional larger atypical cells may be present but are less common. The background shows normocytic red cells with normal distribution; platelets are not prominent. This cytomorphology supports SMZL in the context of known splenomegaly or lymphoproliferative disease and is often corroborated by immunophenotyping and molecular studies. Clinically, peripheral blood involvement occurs in roughly half to two-thirds of SMZL cases and helps establish disease burden. The image illustrates the diagnostic utility of meticulous peripheral smear review for small-vessel lymphocytosis and villous lymphocytes, informing differential diagnoses, guiding flow cytometry panels, and contributing to monitoring and prognosis.

This image depicts a peripheral blood smear prepared with Wright-Giemsa stain and examined under light microscopy at high magnification. The predominant features are small, mature-appearing lymphocytes with scant cytoplasm and discrete basophilic nuclei interspersed among erythrocytes. A characteristic subset of circulating lymphocytes displays short, polarity-restricted cytoplasmic villi (finger-like projections) consistent with splenic marginal zone lymphoma (SMZL) involvement of peripheral blood. The villi are typically slender and localized to one pole of the cell, unlike the longer, circumferential villous extensions seen in hairy cell leukemia, which aids in differential diagnosis. Some lymphocytes appear slightly irregular or irregular nuclear contours; occasional larger atypical cells may be present but are less common. The background shows normocytic red cells with normal distribution; platelets are not prominent. This cytomorphology supports SMZL in the context of known splenomegaly or lymphoproliferative disease and is often corroborated by immunophenotyping and molecular studies. Clinically, peripheral blood involvement occurs in roughly half to two-thirds of SMZL cases and helps establish disease burden. The image illustrates the diagnostic utility of meticulous peripheral smear review for small-vessel lymphocytosis and villous lymphocytes, informing differential diagnoses, guiding flow cytometry panels, and contributing to monitoring and prognosis.

Peripheral blood smear prepared from a patient with suspected plasma cell leukemia (PCL) was examined by bright‑field light microscopy after Wright‑Giemsa staining. The smear shows several circulating plasma‑cell–like elements, including four conspicuous proplasmacytes with dispersed nuclear chromatin and prominent nucleoli, as indicated by arrows in the original figure. In addition, background erythrocytes exhibit rouleaux formation, a common feature in paraproteinemic states. The cells display eccentrically placed nuclei with pronounced basophilic cytoplasm and a coarse chromatin pattern; occasional cells show a perinuclear clearing (Golgi rim) suggestive of plasmacytic differentiation. Immunoglobulin light‑chain restriction is not determined on this smear alone but flow cytometry or immunohistochemistry would typically confirm clonal plasma cells. Relative proportions indicate that neoplastic plasma cells constitute a substantial fraction of leukocytes, consistent with plasma cell leukemia rather than reactive plasmacytosis. PCL is an aggressive myelomatous process often presenting with cytopenias, organomegaly, and sometimes lymphadenopathy; prognosis is poor, and treatment responsiveness is limited. This image illustrates characteristic morphologic features used for differential diagnosis against multiple myeloma, Waldenström macroglobulinemia, and other causes of plasmacytosis. Clinically relevant keywords include plasma cells, rouleaux, Wright‑Giemsa stain, 100X oil, peripheral blood, leukemia, myeloma, and hematologic malignancy.

Peripheral blood smear prepared from a patient with suspected plasma cell leukemia (PCL) was examined by bright‑field light microscopy after Wright‑Giemsa staining. The smear shows several circulating plasma‑cell–like elements, including four conspicuous proplasmacytes with dispersed nuclear chromatin and prominent nucleoli, as indicated by arrows in the original figure. In addition, background erythrocytes exhibit rouleaux formation, a common feature in paraproteinemic states. The cells display eccentrically placed nuclei with pronounced basophilic cytoplasm and a coarse chromatin pattern; occasional cells show a perinuclear clearing (Golgi rim) suggestive of plasmacytic differentiation. Immunoglobulin light‑chain restriction is not determined on this smear alone but flow cytometry or immunohistochemistry would typically confirm clonal plasma cells. Relative proportions indicate that neoplastic plasma cells constitute a substantial fraction of leukocytes, consistent with plasma cell leukemia rather than reactive plasmacytosis. PCL is an aggressive myelomatous process often presenting with cytopenias, organomegaly, and sometimes lymphadenopathy; prognosis is poor, and treatment responsiveness is limited. This image illustrates characteristic morphologic features used for differential diagnosis against multiple myeloma, Waldenström macroglobulinemia, and other causes of plasmacytosis. Clinically relevant keywords include plasma cells, rouleaux, Wright‑Giemsa stain, 100X oil, peripheral blood, leukemia, myeloma, and hematologic malignancy.

Searching Images

eosinophilia peripheral blood eosinophil granules

Histopathology; Hematoxylin and Eosin stained gallbladder tissue demonstrating pure eosinophilic infiltrate within the lamina propria. The mucosal architecture is preserved without stromal necrosis or significant neutrophilic infiltration. Eosinophils appear as round to irregular cells with bilobed or multilobed nuclei and abundant bright pink-orange cytoplasmic granules, forming dense networks in the lamina propria surrounding ductal structures and capillaries. The submucosa is largely unremarkable, and no mural granulomas or ulceration are evident. Vascular congestion may be present secondary to inflammatory edema. Scattered lymphocytes and plasma cells are minimal, with eosinophils constituting the predominant inflammatory cell type. A scattered macrophage population is observed adjacent to small vessels. No gallstones are visible in this field, and there is no evidence of acute neutrophilic cholangitis. This pattern is characteristic of eosinophilic cholecystitis, a rare inflammatory variant often linked to allergic or parasitic processes, drug reactions, or hypereosinophilic syndrome. Clinically, eosinophilic cholecystitis may present with right upper quadrant pain and cholecystitis-like symptoms, but peripheral eosinophilia or serologic allergy markers may be absent. The diagnostic significance lies in recognizing eosinophil-predominant inflammation, guiding differential diagnosis, investigative workup for eosinophilia, and management focusing on underlying triggers and symptomatic gallbladder relief.

Histopathology; Hematoxylin and Eosin stained gallbladder tissue demonstrating pure eosinophilic infiltrate within the lamina propria. The mucosal architecture is preserved without stromal necrosis or significant neutrophilic infiltration. Eosinophils appear as round to irregular cells with bilobed or multilobed nuclei and abundant bright pink-orange cytoplasmic granules, forming dense networks in the lamina propria surrounding ductal structures and capillaries. The submucosa is largely unremarkable, and no mural granulomas or ulceration are evident. Vascular congestion may be present secondary to inflammatory edema. Scattered lymphocytes and plasma cells are minimal, with eosinophils constituting the predominant inflammatory cell type. A scattered macrophage population is observed adjacent to small vessels. No gallstones are visible in this field, and there is no evidence of acute neutrophilic cholangitis. This pattern is characteristic of eosinophilic cholecystitis, a rare inflammatory variant often linked to allergic or parasitic processes, drug reactions, or hypereosinophilic syndrome. Clinically, eosinophilic cholecystitis may present with right upper quadrant pain and cholecystitis-like symptoms, but peripheral eosinophilia or serologic allergy markers may be absent. The diagnostic significance lies in recognizing eosinophil-predominant inflammation, guiding differential diagnosis, investigative workup for eosinophilia, and management focusing on underlying triggers and symptomatic gallbladder relief.

Histopathology: Light microscopy of a gastrointestinal mucosal biopsy stained with Hematoxylin and Eosin reveals a dense inflammatory infiltrate within the lamina propria. The predominant cellular population comprises eosinophils, characterized by bilobed or irregular nuclei and abundant bright pink cytoplasmic granules, intermixed with a smaller number of mononuclear lymphocytes. Epithelial architecture within this field shows intact surface epithelium without definite crypt distortion or ulceration; no granulomas or conspicuous vasculitis are evident in the sampled area. The surrounding stroma appears mildly edematous with scattered plasma cells and occasional neutrophils. In this image, the eosinophilic infiltrate is conspicuous and may extend around mucosal glands and vessels. Such a pattern is compatible with eosinophilic gastroenteritis or hypersensitivity reactions and could reflect parasitic infection, drug-induced hypersensitivity, or food allergy, depending on clinical context. Normal variant eosinophil counts in the lamina propria can be elevated in the GI tract; therefore correlation with peripheral eosinophilia and clinical symptoms is essential. Diagnostic significance: the presence of tissue eosinophilia in the lamina propria supports a non-neoplastic inflammatory process; differential diagnoses include eosinophilic colitis/enteritis, inflammatory bowel disease with eosinophilia, or secondary eosinophilia due to parasites. Clinical correlation with symptoms (abdominal pain, diarrhea), stool studies, and serologies is recommended.

Histopathology: Light microscopy of a gastrointestinal mucosal biopsy stained with Hematoxylin and Eosin reveals a dense inflammatory infiltrate within the lamina propria. The predominant cellular population comprises eosinophils, characterized by bilobed or irregular nuclei and abundant bright pink cytoplasmic granules, intermixed with a smaller number of mononuclear lymphocytes. Epithelial architecture within this field shows intact surface epithelium without definite crypt distortion or ulceration; no granulomas or conspicuous vasculitis are evident in the sampled area. The surrounding stroma appears mildly edematous with scattered plasma cells and occasional neutrophils. In this image, the eosinophilic infiltrate is conspicuous and may extend around mucosal glands and vessels. Such a pattern is compatible with eosinophilic gastroenteritis or hypersensitivity reactions and could reflect parasitic infection, drug-induced hypersensitivity, or food allergy, depending on clinical context. Normal variant eosinophil counts in the lamina propria can be elevated in the GI tract; therefore correlation with peripheral eosinophilia and clinical symptoms is essential. Diagnostic significance: the presence of tissue eosinophilia in the lamina propria supports a non-neoplastic inflammatory process; differential diagnoses include eosinophilic colitis/enteritis, inflammatory bowel disease with eosinophilia, or secondary eosinophilia due to parasites. Clinical correlation with symptoms (abdominal pain, diarrhea), stool studies, and serologies is recommended.

Searching Images

leukemoid reaction left shift band neutrophils myelocytes blood smear

A multi-panel figure containing diagnostic imaging, an electrocardiogram (ECG), and a blood smear. Panel A presents axial PET/CT fusion and CT images of the thoracic and upper abdominal regions, showing a soft tissue mass near the esophageal hiatus and retroperitoneal abdominal trunk with hypermetabolic fluorodeoxyglucose (FDG) uptake, indicating tumor recurrence or metastasis. Panel B displays a 12-lead ECG strip demonstrating arrhythmias including premature atrial contractions (PACs) and premature ventricular contractions (PVCs). Green arrows highlight mild ST-segment depression in leads V5 and V6, while the blue arrow points to significant T-wave morphology changes, suggesting immunotherapy-related myocardial injury. Panel C is a peripheral blood smear micrograph showing two neutrophils with a left shift in nuclei (indicated by blue arrows), characterized by immature band forms, which is suggestive of an acute inflammatory response or infection. This composite illustrates the clinical monitoring of a patient with esophageal squamous cell carcinoma experiencing immune-related adverse events.

A multi-panel figure containing diagnostic imaging, an electrocardiogram (ECG), and a blood smear. Panel A presents axial PET/CT fusion and CT images of the thoracic and upper abdominal regions, showing a soft tissue mass near the esophageal hiatus and retroperitoneal abdominal trunk with hypermetabolic fluorodeoxyglucose (FDG) uptake, indicating tumor recurrence or metastasis. Panel B displays a 12-lead ECG strip demonstrating arrhythmias including premature atrial contractions (PACs) and premature ventricular contractions (PVCs). Green arrows highlight mild ST-segment depression in leads V5 and V6, while the blue arrow points to significant T-wave morphology changes, suggesting immunotherapy-related myocardial injury. Panel C is a peripheral blood smear micrograph showing two neutrophils with a left shift in nuclei (indicated by blue arrows), characterized by immature band forms, which is suggestive of an acute inflammatory response or infection. This composite illustrates the clinical monitoring of a patient with esophageal squamous cell carcinoma experiencing immune-related adverse events.

This hematology infographic illustrates the metabolic reprogramming of neutrophils during homeostasis. The top panel depicts neutrophil development (granulopoiesis) from hematopoietic stem cells (HSCs) through various stages: Myeloblast (MB), Promyelocyte (PM), Myelocyte (MC), Metamyelocyte (MM), Band cell (BC), and segmented Neutrophil (SN). Morphological changes show nuclear progression from round/ovoid to indented and ultimately multi-lobed. The bottom panel highlights a significant immunometabolic shift. Immature stages (HSCs to Metamyelocytes) are predominantly reliant on mitochondrial respiration, utilizing fatty acids and glucose to fuel the TCA cycle and oxidative phosphorylation (OXPHOS) for ATP generation; this metabolic state sustains early cellular differentiation. In contrast, mature neutrophils (Band cells and SNs) transition to being predominantly reliant on glycolysis. In these mature cells, glucose and glycogen fuel the pentose phosphate pathway and glycolysis to produce ATP, which sustains effector functions including chemotaxis, ROS production, apoptosis, and NET formation. The diagram emphasizes the shift from high mitochondrial activity in progenitors to glycolytic dominance in terminally differentiated innate immune cells.

This hematology infographic illustrates the metabolic reprogramming of neutrophils during homeostasis. The top panel depicts neutrophil development (granulopoiesis) from hematopoietic stem cells (HSCs) through various stages: Myeloblast (MB), Promyelocyte (PM), Myelocyte (MC), Metamyelocyte (MM), Band cell (BC), and segmented Neutrophil (SN). Morphological changes show nuclear progression from round/ovoid to indented and ultimately multi-lobed. The bottom panel highlights a significant immunometabolic shift. Immature stages (HSCs to Metamyelocytes) are predominantly reliant on mitochondrial respiration, utilizing fatty acids and glucose to fuel the TCA cycle and oxidative phosphorylation (OXPHOS) for ATP generation; this metabolic state sustains early cellular differentiation. In contrast, mature neutrophils (Band cells and SNs) transition to being predominantly reliant on glycolysis. In these mature cells, glucose and glycogen fuel the pentose phosphate pathway and glycolysis to produce ATP, which sustains effector functions including chemotaxis, ROS production, apoptosis, and NET formation. The diagram emphasizes the shift from high mitochondrial activity in progenitors to glycolytic dominance in terminally differentiated innate immune cells.

Note on sources: Dacie & Lewis (Practical Haematology) and McKenzie's Clinical Laboratory Hematology are not in the textbook library. These notes draw from the next-best equivalents available: Henry's Clinical Diagnosis and Management by Laboratory Methods (the premier laboratory medicine reference), Robbins & Cotran Pathologic Basis of Disease, Goldman-Cecil Medicine, and Quick Compendium of Clinical Pathology - all of which cover WBC disorders at the same depth and are frequently cited alongside Dacie/McKenzie for pathology boards.

WBC (Leukocyte) Disorders

Comprehensive Notes for Pathology Residents


SECTION 1 - NORMAL REFERENCE RANGES

Cell TypeAdult Reference Range
Total WBC4.8-10.8 × 10³/µL
Neutrophils1.8-7.0 × 10³/µL (40-70%)
Lymphocytes1.5-4.0 × 10⁹/L (20-40%)
Monocytes0.1-0.8 × 10⁹/L (~4%)
Eosinophils0-0.5 × 10³/µL
Basophils0-0.2 × 10³/µL
Key principle: Always use absolute counts, not relative percentages. Relative lymphocytosis can be entirely due to neutropenia without a true increase in lymphocytes.

SECTION 2 - LEUKOCYTOSIS: OVERVIEW

Leukocytosis = increase in total WBC count. The peripheral blood leukocyte count is controlled by four factors (Robbins):
  1. Size of myeloid/lymphoid precursor and storage pools in BM, thymus, and tissues
  2. Rate of release from storage pools into circulation
  3. Proportion adherent to vessel walls (the marginal granulocyte pool, MGP)
  4. Rate of extravasation into tissues
The MGP and circulating granulocyte pool (CGP) are approximately equal in size and in dynamic equilibrium.

SECTION 3 - NEUTROPHILIC DISORDERS

3.1 Neutrophilia (Neutrophilic Leukocytosis)

Definition: Absolute neutrophil count >7.0 × 10³/µL in adults.

Mechanisms (Henry's):

MechanismExamples
Redistribution from MGP to CGPExercise, epinephrine, stress, glucocorticoids
Increased BM releaseAcute infection, inflammation (TNF, IL-1 mediated)
Increased BM productionChronic infection, G-CSF, myeloproliferative neoplasms (MPN)
Decreased egress to tissuesGlucocorticoids (block ICAM/selectin interactions)

Causes (Robbins Table 13.2/13.3):

  • Acute bacterial infections (especially pyogenic organisms) - commonest cause
  • Sterile tissue necrosis (myocardial infarction, burns, surgery)
  • Metabolic disorders (uremia, diabetic ketoacidosis, eclampsia, gout)
  • Drugs (glucocorticoids, lithium, G-CSF)
  • Physiologic (neonates, pregnancy, exercise)
  • Chronic inflammation (growth factor-dependent)
  • Paraneoplastic (e.g., Hodgkin lymphoma - growth factor-dependent)
  • Myeloproliferative neoplasms (growth factor-independent)
Pearl: Physiologic leukocytosis from exercise/epinephrine is transient and normalizes within 30-60 minutes. No band/left shift is expected.

3.2 Qualitative Neutrophil Abnormalities

Toxic Changes (Henry's) - Acquired

Seen in infections, toxic/inflammatory conditions:
FindingDescription
Toxic granulationDark blue-purple cytoplasmic granules (peroxidase-positive); represent primary granules that failed to lose their staining properties
Döhle inclusion bodiesSmall pale-blue oval inclusions in peripheral cytoplasm (Wright's stain); remnants of free ribosomes/rough ER from earlier developmental stage
Cytoplasmic vacuolationPhagocytic vacuoles; strong indicator of bacterial sepsis when combined with toxic granulation
Hypersegmentation≥5 lobes in >5% of neutrophils; classic for B12/folate deficiency; also uremia

Hereditary/Constitutional Anomalies (Henry's)

AnomalyGeneticsMorphologyFunction
May-Hegglin anomalyMYH9 gene, chr 22q12-13, autosomal dominantLarge Döhle-like pale blue RNA inclusions in ALL granulocytes + giant platelets ± thrombocytopeniaNormal
Alder-Reilly anomalyMucopolysaccharidoses (Hurler, Hunter, etc.)Dense, large azurophilic granules in ALL WBCs (resembles toxic granulation but NOT transient); metachromatic lymphocyte inclusions (Gasser cells)Normal granulocyte function
Chediak-Higashi syndromeLYST gene, autosomal recessiveGiant fused lysosomes (giant granules) in granulocytes, lymphocytes, NK cells; partial oculocutaneous albinismSeverely impaired (recurrent pyogenic infections, NK cell dysfunction)
Pelger-Huet anomalyLBR gene, autosomal dominantHyposegmented neutrophils (bilobed "pince-nez"/dumbbell nuclei, or round/ovoid); coarse chromatinNormal - clinically benign
Pseudo-Pelger-HuetAcquired (MDS, drugs, infection)Identical morphology but acquired; important to distinguish from true Pelger-HuetNormal
Exam pearl: In May-Hegglin, Sebastian, Fechtner, and Epstein syndromes - all are MYH9-related, all have Döhle-like inclusions and giant platelets. Fechtner and Epstein additionally have nephritis and sensorineural hearing loss.

3.3 Neutropenia

Definition: Absolute neutrophil count <1.8 × 10³/µL (or <1.0 × 10³/µL in young children).
Severity: Mild: 1.0-1.8 × 10³/µL | Moderate: 0.5-1.0 | Severe: <0.5 (agranulocytosis)

Causes:

Decreased production:
  • Aplastic anemia, chemotherapy, radiation
  • B12/folate deficiency (ineffective granulopoiesis)
  • Myelophthisis (marrow replacement by tumor, granuloma, fibrosis)
  • Congenital: Kostmann syndrome (severe congenital neutropenia - HAX1 mutation), cyclic neutropenia (ELANE gene, 21-day cycles)
  • Myelodysplastic syndrome
Increased destruction/consumption:
  • Immune: autoimmune neutropenia, drug-induced (quinidine, propylthiouracil, clozapine, sulfonamides), isoimmune neonatal neutropenia
  • Hypersplenism
  • Overwhelming sepsis (in neonates and elderly - important exam pearl)
Redistribution/sequestration:
  • Pseudoneutropenia (benign ethnic neutropenia in people of African descent - MGP enlarged at expense of CGP, ANC can be as low as 0.2; normal bone marrow; no increased infection risk)
Special infections causing neutropenia (Quick Compendium):
  • Typhoid fever, Brucellosis, Tularemia, Rickettsial infection (cause relative neutropenia)
  • Felty syndrome (RA + splenomegaly + neutropenia)

SECTION 4 - EOSINOPHILIC DISORDERS

4.1 Eosinophilia

Definition: Absolute eosinophil count >0.5 × 10³/µL
Grading:
  • Mild: 0.5-1.5 × 10³/µL
  • Moderate: 1.5-5.0 × 10³/µL
  • Severe: >5.0 × 10³/µL (hypereosinophilia)

Causes (Robbins Table 13.3):

  • Allergic disorders - asthma, allergic rhinitis, atopic dermatitis (IL-5 driven)
  • Parasitic infestations - tissue-invasive parasites (Toxocara, Trichinella, Strongyloides); NOT intestinal protozoa
  • Drug reactions - penicillin, aspirin, sulfonamides
  • Malignancies - Hodgkin lymphoma (most important), some NHL; paraneoplastic
  • Autoimmune/skin - pemphigus, dermatitis herpetiformis, eosinophilic fasciitis
  • Vasculitides - eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
  • Atherosclerotic embolism (transient)
  • Adrenal insufficiency (Addison's)
  • Hypereosinophilic syndrome (HES): persistent eosinophilia >1.5 × 10³/µL for >6 months with end-organ damage (heart, lung, CNS, skin); must exclude reactive and clonal causes
  • Clonal eosinophilia: FIP1L1-PDGFRA fusion (imatinib-responsive), ETV6-PDGFRB; classified as myeloid/lymphoid neoplasm with eosinophilia
Morphology clue (Henry's): In hypereosinophilic syndrome, eosinophils may show cytoplasmic vacuolation, reduced or absent granules (degranulation), and nuclear hyperlobulation - indicating activated/degranulating eosinophils.

SECTION 5 - BASOPHILIC DISORDERS

5.1 Basophilia

Definition: Absolute basophil count >0.2 × 10³/µL
Key causes (Henry's, Box 34.5):
  • Myeloproliferative neoplasms - MOST IMPORTANT (especially CML; basophilia >20% suggests blast phase transformation)
  • Allergic reactions (food, drugs, foreign proteins)
  • Inflammatory bowel disease
  • Infections: variola (smallpox), varicella
  • Hypothyroidism
Critical pearl: Basophilia almost always signals a myeloproliferative neoplasm (especially CML) when absolute basophilia is sustained. Always check BCR-ABL1.

SECTION 6 - MONOCYTIC DISORDERS

6.1 Morphology (Henry's)

Monocyte: largest normal blood cell (14-20 µm). Kidney/horseshoe-shaped nucleus, fine parallel chromatin strands, blue-gray "ground-glass" cytoplasm, fine azurophilic granules. Monocytes average 4% of leukocytes.

6.2 Monocytosis

Definition: Absolute monocyte count >0.8 × 10⁹/L (some labs use >1.0)
Causes (Henry's - landmark study by Maldonado 1965, 160 cases):
  • 50% of absolute monocytosis cases were associated with hematologic neoplasms: AML (especially monocytic), lymphoma (Hodgkin predominant), multiple myeloma, MPN
  • Infectious: tuberculosis, brucellosis, bacterial endocarditis, syphilis (but uncommon)
  • Inflammatory: SLE, RA, IBD
  • Post-splenectomy/recovery from agranulocytosis
  • Myelodysplastic syndrome (chronic myelomonocytic leukemia - CMML)
Important: The classic finding in CMML is persistent monocytosis >1.0 × 10⁹/L for >3 months with clonal cytogenetic/molecular features.

6.3 Monocytopenia

Definition: <0.2 × 10⁹/L
Causes (Henry's):
  • Hairy cell leukemia (classic association - virtually pathognomonic)
  • Prednisone (falls within first hours of first dose, returns by 12h)
  • MonoMac syndrome (GATA2 mutation) - monocytopenia + susceptibility to mycobacterial and fungal infections + NK cell deficiency
  • B-lymphoblastic leukemia
  • Chemotherapy (monocytopenia heralds onset of neutropenia - Quick Compendium)

SECTION 7 - LYMPHOCYTIC DISORDERS

7.1 Normal Lymphocytes (Henry's)

  • Small lymphocytes: 6-10 µm, single sharply defined nucleus, heavy chromatin blocks, scant pale cytoplasm
  • Large lymphocytes (LGLs): 12-16 µm, indented/folded nucleus, pale gray-blue cytoplasm with azurophilic granules
  • Adults: lymphocytes = 20-40% of WBCs (1.5-4.0 × 10⁹/L)
  • Children up to 5 years: lymphocytes up to 50% (highest in 1st year)
  • Normal CD4:CD8 ratio = 1.0-3.4

7.2 Lymphocytosis

Definition: >4.0 × 10⁹/L in adults; >8.8 × 10⁹/L in children
Causes by mechanism:

Reactive (Non-neoplastic) Lymphocytosis (Henry's):

CauseLymphocyte TypeKey Features
EBV (infectious mononucleosis)Reactive T cells (CD8+)Atypical lymphocytes (Downey cells); heterophile antibody positive; splenomegaly; pharyngitis; lymphadenopathy
CMV mononucleosisReactive T cellsSimilar to EBV but heterophile NEGATIVE; milder pharyngitis
HepatitisReactive lymphocytesElevated transaminases
Acute infectious lymphocytosisSmall mature T cellsChildren; WBC 20-50 × 10⁹/L; normal morphology; no adenopathy/splenomegaly; lasts 3-5 weeks
Pertussis (whooping cough)Small mature T cells, normal CD4:CD8WBC can exceed 30 × 10⁹/L; HIGHEST in week 1-3; caused by pertussis toxin (PT) blocking chemokine G-coupled receptors, preventing lymphocyte retention in BM/spleen - redistribution, NOT increased lymphopoiesis
Adenovirus, varicella, measles, rubellaReactiveMild lymphocytosis
Stress lymphocytosisPolyclonalAcute (trauma, MI, surgery); transient
Atypical lymphocytes (Reactive Lymphocytes/Downey cells - Henry's):
  • Larger than normal small lymphocytes
  • Irregular, indented, or lobulated nuclei; dispersed chromatin
  • Abundant pale-blue cytoplasm, often "scalloped" by adjacent RBCs
  • NOT the same as neoplastic cells; they are activated T cells
  • Three types: Type I (Rieder/band forms), Type II (monocytoid), Type III (blast-like)

7.3 Lymphopenia

Definition: <1.5 × 10⁹/L in adults
Causes (Quick Compendium):
  • HIV infection (CD4+ T cell loss)
  • SLE (anti-lymphocyte antibodies)
  • Steroid therapy
  • Anti-CD20 (rituximab) therapy
  • Severe acute respiratory syndrome (SARS/COVID-19)
  • Congenital immunodeficiency: Bruton's X-linked agammaglobulinemia, SCID, DiGeorge syndrome, common variable immunodeficiency (CVID)
  • Radiation/chemotherapy
  • Malnutrition (protein-calorie)

SECTION 8 - LEUKEMOID REACTION vs CML

8.1 Leukemoid Reaction

Definition: Extreme reactive leukocytosis (WBC >50 × 10⁹/L) with a "left shift" (presence of immature granulocytes - band forms, metamyelocytes, myelocytes) that resembles leukemia.
Causes: Severe infection (tuberculosis, pertussis, meningitis), drugs (G-CSF), hemolysis, solid tumor metastases to BM (leukoerythroblastic reaction).
Key distinction from CML:
FeatureLeukemoid ReactionCML
LAP score (Leukocyte Alkaline Phosphatase)High (>100)Low (<10)
BCR-ABL1 (Philadelphia chromosome)AbsentPresent (>95%)
BasophiliaAbsent/mildProminent
SplenomegalyAbsent/mildMarked
Underlying causeIdentifiable (infection, drug)None
EosinophiliaAbsent/mildOften present
Toxic changesPresentAbsent
Pearl: The LAP score has largely been replaced by BCR-ABL1 testing in clinical practice, but remains on exams as the classic differentiator.

SECTION 9 - NEOPLASTIC WBC DISORDERS: CLASSIFICATION FRAMEWORK

The WHO classification (per Robbins/Goldman-Cecil) categorizes leukocyte neoplasms by:
  1. Cell of origin (myeloid vs. lymphoid; B vs. T vs. NK)
  2. Maturation state (precursor/blast vs. mature)
  3. Cytogenetic and molecular alterations
  4. Clinical behavior (acute vs. chronic)

9.1 Major Categories

A. Myeloid Neoplasms

EntityKey Features
Acute Myeloid Leukemia (AML)≥20% blasts in BM/blood; myeloperoxidase positive; Auer rods pathognomonic; FAB M0-M7 classification
Myeloproliferative Neoplasms (MPN)Clonal, effective maturation; increased output of one or more cell lines
- CMLBCR-ABL1 t(9;22); basophilia; splenomegaly; LAP low
- Polycythemia veraJAK2 V617F (>95%); elevated RBC mass; low EPO
- Essential thrombocythemiaJAK2 (55%), CALR (25%), MPL mutations; platelets >450
- Primary myelofibrosisJAK2/CALR/MPL; leukoerythroblastosis; teardrop RBCs
Myelodysplastic Syndrome (MDS)Dysplasia + ineffective hematopoiesis; cytopenias; ring sideroblasts; may transform to AML
CMMLMonocytes >1.0 × 10⁹/L; dysplasia; ASXL1, TET2 mutations

B. Lymphoid Neoplasms

EntityImmunophenotypeKey MolecularClinical
B-ALL/LBLTdT+, CD10+, CD19+, CD34+BCR-ABL1 (poor prognosis), ETV6-RUNX1 (good), hyperdiploidyChildhood peak; BM/blood; CNS involvement
T-ALL/LBLTdT+, CD3+, CD7+; mediastinalNOTCH1 mutationsAdolescent males; anterior mediastinal mass
CLL/SLLCD5+, CD19+, CD23+, CD20 (weak), FMC7-; smudge cells17p del (worst), 11q del, trisomy 12, 13q del (best)Adults; indolent; Richter transformation
Follicular lymphomaCD10+, BCL2+, CD20+t(14;18) BCL2-IGHAdults; follicular growth; waxing/waning
Mantle cell lymphomaCD5+, CD20+, cyclin D1+, BCL2+, FMC7+t(11;14) CCND1-IGHMiddle-aged males; mantle zone pattern; aggressive
DLBCLCD20+, CD19+; variable BCL2, BCL6, MYCMYC rearrangement (double/triple-hit = very aggressive)Most common NHL; diffuse large B cells
Burkitt lymphomaCD20+, CD10+, BCL6+, BCL2-t(8;14) or t(2;8), t(8;22) MYC translocation; Ki67 ~100%"Starry sky" pattern; jaw (endemic); ileocecal (sporadic)
Multiple myelomaCD138+, CD38+, CD56+, CD19-, CD45-t(4;14), t(14;16), del17p (high risk); FISH for stagingBone pain, hypercalcemia, renal failure, anemia (CRAB)
Hodgkin lymphomaRS cells: CD15+, CD30+, CD20-, LCA-EBV association (esp. mixed cellularity, LDHL)Bimodal age; mediastinal mass; B symptoms

SECTION 10 - KEY IMMUNOPHENOTYPING MARKERS (Robbins, Table 13.5)

MarkerExpression
CD3T cells (all mature)
CD4Helper T cells
CD5T cells + small subset B cells (also CLL, MCL)
CD8Cytotoxic T cells
CD10Pre-B cells, germinal center B cells (ALL, FL, Burkitt)
CD19Pre-B to mature B cells (not plasma cells)
CD20Pre-B (after CD19) to mature B cells (not plasma cells) - rituximab target
CD21Mature B cells, follicular dendritic cells (EBV receptor)
CD23Activated mature B cells (CLL+; MCL-)
CD30Activated B and T cells; Reed-Sternberg cells
CD34Hematopoietic stem/progenitor cells; blasts
CD45 (LCA)All leukocytes
TdTPrecursor B and T cells (blasts)
MPOMyeloid lineage
CD138Plasma cells
CD11cGranulocytes, monocytes, macrophages; also hairy cell leukemia
CD14Monocytes
CD15Granulocytes; Reed-Sternberg cells
CD56NK cells; subset T cells; also myeloma cells

SECTION 11 - MORPHOLOGY PEARLS FOR PATHOLOGY SIGN-OUT

MorphologyAssociated Condition
Smudge/basket cellsCLL (fragile leukemic lymphocytes)
Auer rodsAML (fused primary granules - pathognomonic for myeloid lineage)
"Starry sky" patternBurkitt lymphoma (tingible body macrophages amidst tumor cells)
"Hair-like" projectionsHairy cell leukemia (TRAP+, annexin A1+, CD11c+, CD25+, CD103+)
Bilobed "mirror-image" RS cellsClassical Hodgkin lymphoma
Lacunar cellsNodular sclerosing Hodgkin lymphoma
Lymphocyte-predominant "popcorn" cellsNLPHL (CD20+, CD45+, CD15-, CD30-)
Cerebriform (Sézary) cellsSézary syndrome/Mycosis fungoides (CD4+ T-cell)
Bilobed/dumbbell neutrophilsPelger-Huet anomaly
Giant granules in granulocytesChediak-Higashi syndrome
Rouleaux + plasma cells in bloodMultiple myeloma / plasma cell leukemia
Teardrop poikilocytes + leukoerythroblastic picturePrimary myelofibrosis
Villous lymphocytes at one poleSplenic marginal zone lymphoma (SMZL)
Circumferential villiHairy cell leukemia

SECTION 12 - APPROACH TO LEUKOCYTOSIS/LEUKOPENIA (Algorithmic)

When encountering elevated WBC:

  1. Identify the predominant cell type (neutrophilia, lymphocytosis, monocytosis, eosinophilia)
  2. Check for left shift (bands, metamyelocytes, myelocytes in blood)
  3. Assess morphology (toxic changes? atypical cells? blasts?)
  4. Correlate with clinical context (infection, inflammation, drug history, lymphadenopathy)
  5. If WBC >50 × 10⁹/L or blasts identified → pursue BCR-ABL1, flow cytometry, BM biopsy

Red flags requiring immediate workup:

  • Blasts on peripheral smear (any %)
  • WBC >100 × 10⁹/L (leukostasis risk)
  • Unexplained monocytosis >1.0 × 10⁹/L persisting >3 months
  • Basophilia >20% in MPN (blast phase transformation)
  • Lymphocytosis >5.0 × 10⁹/L with monoclonal B cells on flow

Sources

  • Henry's Clinical Diagnosis and Management by Laboratory Methods - Ch. 31, 34 (Leukocytes, Non-neoplastic Disorders)
  • Robbins, Cotran & Kumar Pathologic Basis of Disease - Ch. 13 (Diseases of White Blood Cells and Lymph Nodes)
  • Goldman-Cecil Medicine - Leukocytosis and Leukopenia sections
  • Quick Compendium of Clinical Pathology, 5th ed - Hematopathology section 4.2
  • Goldman-Cecil Medicine - Table 13.2-13.3 (Mechanisms and Causes of Leukocytosis)
This is a shared conversation. Sign in to Orris to start your own chat.